Esomeprazole sodium

• Catalog No.: S2233
• CAS Number: 161796-78-7
• M. F.: C17H18N3NaO3S
• M. W.: 367.39789
• Storage: -20°C

SYNONYMS

• IUPAC name: 5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methanesulfinyl]-1-sodio-1H-1,3-benzodiazole
• IUPAC Traditional name: 5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methanesulfinyl]-1-sodio-1,3-benzodiazole
• Synonyms: Axagon; Nexiam; Zoleri; Sompraz; Lucen; Esopral

DATABASE IDS

• CAS Number: 161796-78-7

PROPERTIES

• Target: ATPase
• Salt Data: Free Base
• Storage Condition: -20°C

DETAILS

Description (English)

Research Area: Cancer
Biological Activity:
Esomeprazole sodium (Nexium) is a sodium salt of esomeprazole that is a potent proton pump inhibitor with an IC50 of 0.076 mg/kg. Esomeprazole sodium (Nexium) suppresses gastric acid secretion by specific inhibition of the H+/K+-ATPase in the gastric parietal cell. Esomeprazole sodium (Nexium) is used in the treatment of dyspepsia, peptic ulcer disease, gastroesophageal reflux disease and Zollinger-Ellison syndrome. Esomeprazole is the S-enantiomer of omeprazole. The S- and R-isomers of omeprazole are protonated and converted in the acidic compartment of the parietal cell forming the active inhibitor, the achiral sulphenamide. By acting specifically on the proton pump, esomeprazole blocks the final step in acid production, thus reducing gastric acidity. This effect is dose-related up to a daily dose of 20 to 40 mg and leads to inhibition of gastric acid secretion. [1][2]

REFERENCES

• Bastaki SM et al. Mol Cell Biochem. 2008 Feb;309(1-2):167-75.